Silke Radetzki

1.1k total citations
25 papers, 756 citations indexed

About

Silke Radetzki is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Silke Radetzki has authored 25 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Silke Radetzki's work include Cell death mechanisms and regulation (7 papers), Cellular transport and secretion (4 papers) and Cancer-related Molecular Pathways (4 papers). Silke Radetzki is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Cellular transport and secretion (4 papers) and Cancer-related Molecular Pathways (4 papers). Silke Radetzki collaborates with scholars based in Germany, China and France. Silke Radetzki's co-authors include Bernd Dörken, Peter T. Daniel, Isrid Sturm, Clarissa von Haefen, Jens Peter von Kries, Klaus Schulze‐Osthoff, Bernhard Gillissen, Martin Neuenschwander, Katrin Friedrich and Reiner U. Jänicke and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Blood.

In The Last Decade

Silke Radetzki

23 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Radetzki Germany 15 517 232 99 90 68 25 756
Mihail Buse Romania 8 511 1.0× 180 0.8× 176 1.8× 71 0.8× 49 0.7× 14 878
Suzanne Hector United States 12 526 1.0× 229 1.0× 124 1.3× 37 0.4× 47 0.7× 16 714
Carmen Aanei France 12 484 0.9× 219 0.9× 205 2.1× 151 1.7× 41 0.6× 22 979
Li-Yuan Bai Taiwan 17 466 0.9× 150 0.6× 99 1.0× 102 1.1× 43 0.6× 42 869
Cristina Bugés Spain 9 387 0.7× 354 1.5× 153 1.5× 61 0.7× 29 0.4× 21 693
Bridget A. Quinn United States 16 454 0.9× 408 1.8× 110 1.1× 168 1.9× 42 0.6× 24 965
Shane O’Grady Ireland 12 611 1.2× 365 1.6× 222 2.2× 81 0.9× 48 0.7× 19 996
Paolo Bonvini Italy 16 721 1.4× 229 1.0× 101 1.0× 105 1.2× 35 0.5× 34 1.0k
Lynn Ueno United States 9 630 1.2× 221 1.0× 148 1.5× 126 1.4× 26 0.4× 13 910
Haolan Wang China 6 520 1.0× 251 1.1× 192 1.9× 86 1.0× 31 0.5× 9 861

Countries citing papers authored by Silke Radetzki

Since Specialization
Citations

This map shows the geographic impact of Silke Radetzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Radetzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Radetzki more than expected).

Fields of papers citing papers by Silke Radetzki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Radetzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Radetzki. The network helps show where Silke Radetzki may publish in the future.

Co-authorship network of co-authors of Silke Radetzki

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Radetzki. A scholar is included among the top collaborators of Silke Radetzki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Radetzki. Silke Radetzki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krauß, M., Haydar Bulut, Valérie Chambon, et al.. (2025). Next-generation small molecule inhibitors of clathrin function acutely inhibit endocytosis. Structure. 33(5). 878–890.e7. 2 indexed citations
2.
Chau, Ngoc, Jing Xue, M. Krauß, et al.. (2024). Inhibition Clathrin Mediated Endocytosis: Pitstop 1 and Pitstop 2 Chimeras. ChemMedChem. 19(20). e202400253–e202400253.
3.
Lesina, Marina, Qinghua Wang, Alexandra Berninger, et al.. (2024). DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue. Angewandte Chemie International Edition. 63(26). e202318485–e202318485. 8 indexed citations
4.
Lesina, Marina, Qinghua Wang, Alexandra Berninger, et al.. (2024). DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue. Angewandte Chemie. 136(26).
5.
Mucka, Patrick, Peter Lindemann, Michael Willenbrock, et al.. (2023). CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors. Cell chemical biology. 30(10). 1303–1312.e3. 5 indexed citations
6.
Yusenko, Maria V., Mattias K. Andersson, Silke Radetzki, et al.. (2021). Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner. Cancer Letters. 520. 132–142. 18 indexed citations
7.
Ostrop, Jenny, Marianne Terndrup Pedersen, François Gerbe, et al.. (2021). A Semi-automated Organoid Screening Method Demonstrates Epigenetic Control of Intestinal Epithelial Differentiation. Frontiers in Cell and Developmental Biology. 8. 618552–618552. 15 indexed citations
8.
Webel, Henry, Talia B. Kimber, Silke Radetzki, et al.. (2020). Revealing cytotoxic substructures in molecules using deep learning. Journal of Computer-Aided Molecular Design. 34(7). 731–746. 43 indexed citations
9.
Merkert, Sylvia, Ruth Olmer, Silke Radetzki, et al.. (2019). High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs. Stem Cell Reports. 12(6). 1389–1403. 33 indexed citations
10.
Juneja, Manisha, Dennis Kobelt, Wolfgang Walther, et al.. (2017). Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1. PLoS Biology. 15(6). e2000784–e2000784. 71 indexed citations
11.
Arkona, Christoph, Silke Radetzki, Kerstin Böhm, et al.. (2015). Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo. ChemMedChem. 10(5). 815–826. 60 indexed citations
12.
Al‐Gharabli, Samer, et al.. (2014). Flexible, polymer-supported synthesis of sphingosine derivatives provides ceramides with enhanced biological activity. Bioorganic & Medicinal Chemistry. 22(19). 5506–5512. 5 indexed citations
13.
Haefen, Clarissa von, Jana Wendt, Marco Sifringer, et al.. (2011). Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. APOPTOSIS. 16(6). 636–651. 18 indexed citations
14.
Roske, Yvette, Silke Radetzki, Anne Diehl, et al.. (2011). Discovery, Structure–Activity Relationship Studies, and Crystal Structure of Nonpeptide Inhibitors Bound to the Shank3 PDZ Domain. ChemMedChem. 6(8). 1411–1422. 34 indexed citations
15.
Wendt, Jana, Silke Radetzki, Clarissa von Haefen, et al.. (2005). Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells. Oncogene. 25(7). 972–980. 63 indexed citations
16.
Sturm, Isrid, Carsten Stephan, Bernhard Gillissen, et al.. (2005). Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death and Differentiation. 13(4). 619–627. 82 indexed citations
17.
Sturm, Isrid, Andrew G. Bosanquet, Silke Radetzki, et al.. (2005). Silencing of APAF‐1 in B‐CLL results in poor prognosis in the case of concomitant p53 mutation. International Journal of Cancer. 118(9). 2329–2336. 17 indexed citations
18.
Radetzki, Silke, Claus‐Henning Köhne, Clarissa von Haefen, et al.. (2002). The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene. 21(2). 227–238. 3 indexed citations
19.
Radetzki, Silke, Claus‐Henning Köhne, Clarissa von Haefen, et al.. (2002). The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene. 21(2). 227–238. 52 indexed citations
20.
Friedrich, Katrin, Thomas Wieder, Clarissa von Haefen, et al.. (2001). Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene. 20(22). 2749–2760. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihail Buse Breakdown of academic impact, for papers by Suzanne Hector Breakdown of academic impact, for papers by Carmen Aanei Breakdown of academic impact, for papers by Li-Yuan Bai Breakdown of academic impact, for papers by Cristina Bugés Breakdown of academic impact, for papers by Bridget A. Quinn Breakdown of academic impact, for papers by Shane O’Grady Breakdown of academic impact, for papers by Paolo Bonvini Breakdown of academic impact, for papers by Lynn Ueno Breakdown of academic impact, for papers by Haolan Wang
Rankless by CCL
2026